Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
UroGen Pharma Ltd. | Chief Financial Officer | Ordinary Shares | 35.3 K | $556 K | $15.78 | Jan 31, 2024 | Direct |
UroGen Pharma Ltd. | Chief Financial Officer | Restricted Stock Units | 12 K | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
URGN | UroGen Pharma Ltd. | Jan 31, 2024 | 1 | $0 | 4/A | Feb 12, 2024 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Jan 31, 2024 | 3 | $0 | 4 | Feb 2, 2024 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Sep 7, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Mar 25, 2022 | 1 | $0 | 4/A | Feb 12, 2024 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Mar 25, 2022 | 1 | $0 | 4 | Mar 29, 2022 | Chief Financial Officer |
URGN | UroGen Pharma Ltd. | Mar 25, 2022 | 0 | $0 | 3 | Mar 29, 2022 | Chief Financial Officer |